India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The company is pursuing the accelerated FDA 505(b)(2) approval pathway for its once-daily oral ondansetron formulation
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
Elanco expects Befrena to launch in the US in the first half of 2026
The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
Lucid-MS represents a potential breakthrough in the treatment of multiple sclerosis
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
Provides pain relief for more than 30 conditions, including chronic back pain, arthritis, and sports injuries
The Phase 1 study will evaluate the safety, tolerability, and pharmacokinetics (PK) of ENV-6946 in healthy volunteers
NUFYMCO BLA has been approved by the USFDA
Subscribe To Our Newsletter & Stay Updated
